The rise of Viagra initially fueled a period of growth for pharma, but recent developments present a murky picture for shareholders. Off-patent competitors are eating into earnings, and ongoing patent challenges add https://georgiaxgjh605251.qodsblog.com/41346221/viagra-and-the-pharmaceutical-industry-a-volatile-play